ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

STAA vs LUCY // OPERATING MARGIN

STAAR Surgical Company (NASDAQ) VS. Innovative Eyewear Inc. (NASDAQ) • 15-METRIC TALLY: STAA 4 — LUCY 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STAA VS. LUCY) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC STAA LUCY SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 76.20% 21.30% +54.90 STAA /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -3.16% — — TIE /fcf-yield <GO>
Operating Margin ACTIVE -38.30% — — TIE /operating-margins <GO>
Net Profit Margin -33.60% -60.00% +26.40 STAA /net-margins <GO>
Revenue Growth (YoY) -23.70% 62.60% -86.30 LUCY /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 7.11 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 4/9 -1.00 LUCY /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 61.8 46.0 +15.75 STAA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.27B $7.2M $1.26B STAA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR STAA REV LUCY REV STAA GROSS % LUCY GROSS % STAA FCF LUCY FCF
FY 2025 $239.4M $2.7M 76.2% 21.3% -$40.0M -$7.3M
FY 2024 $313.9M $1.6M 76.3% 13.1% -$7.7M -$6.8M
FY 2023 $322.4M $1.2M — — $14.6M -$5.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STAA // BETA —
LUCY // BETA —